pergolide has been researched along with Brain Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duvoisin, RC; Heikkila, RE; Manzino, L | 1 |
| Demenge, P; Fage, D; Feuerstein, C; Guerin, B; Scatton, B | 1 |
| Boyce, S; Jenner, P; Marsden, CD | 1 |
1 review(s) available for pergolide and Brain Diseases
| Article | Year |
|---|---|
Receptor changes during chronic dopaminergic stimulation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain Diseases; Bromocriptine; Dopamine; Humans; Hydroxydopamines; Injections, Intraperitoneal; Levodopa; Neurotransmitter Agents; Oxidopamine; Parkinson Disease; Pergolide; Primates; Pyridines; Receptors, Dopamine; Substance Withdrawal Syndrome | 1988 |
2 other study(ies) available for pergolide and Brain Diseases
| Article | Year |
|---|---|
Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathway.
Topics: Animals; Behavior, Animal; Brain Diseases; Bromocriptine; Ergolines; Female; Hydroxydopamines; Oxidopamine; Parkinson Disease; Pergolide; Rats; Rats, Inbred Strains | 1982 |
Time course of the changes in striatal acetylcholine levels induced by pergolide and haloperidol after lesion of the nigrostriatal dopaminergic pathways in the rat.
Topics: Acetylcholine; Animals; Brain Diseases; Corpus Striatum; Dopamine; Ergolines; Haloperidol; Male; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Substantia Nigra | 1984 |